Your search returned 44 results.

Results
	1.	Targeting mutant fibroblast growth factor receptors in cancer. [electronic resource] by Greulich, Heidi Pollock, Pamela M Producer: 20110830 In: Trends in molecular medicine vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A genome-based strategy uncovers frequent BRAF mutations in melanoma. [electronic resource] by Pollock, Pamela M Meltzer, Paul S Producer: 20030325 In: Cancer cell vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Lineage-specific biomarkers predict response to FGFR inhibition. [electronic resource] by Loch, David C Pollock, Pamela M Producer: 20130813 In: Cancer discovery vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Lucky draw in the gene raffle. [electronic resource] by Pollock, Pamela M Meltzer, Paul S Producer: 20020719 In: Nature vol. 417 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Paralog-Specific Kinase Inhibition of FGFR4: Adding to the Arsenal of Anti-FGFR Agents. [electronic resource] by Packer, Leisl M Pollock, Pamela M Producer: 20160113 In: Cancer discovery vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	FGFR2 as a molecular target in endometrial cancer. [electronic resource] by Byron, Sara A Pollock, Pamela M Producer: 20090430 In: Future oncology (London, England) vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Fibroblast growth factor receptor inhibition synergizes with Paclitaxel and Doxorubicin in endometrial cancer cells. [electronic resource] by Byron, Sara A Loch, David C Pollock, Pamela M Producer: 20130417 In: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	XIAP downregulation accompanies mebendazole growth inhibition in melanoma xenografts. [electronic resource] by Doudican, Nicole A Byron, Sara A Pollock, Pamela M Orlow, Seth J Producer: 20130523 In: Anti-cancer drugs vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk. [electronic resource] by Zhao, Zhen Zhen Pollock, Pamela M Thomas, Shane Treloar, Susan A Nyholt, Dale R Montgomery, Grant W Producer: 20080722 In: Human reproduction (Oxford, England) vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Notch and NOXA-related pathways in melanoma cells. [electronic resource] by Nickoloff, Brian J Hendrix, Mary J C Pollock, Pamela M Trent, Jeffrey M Miele, Lucio Qin, Jian-Zhong Producer: 20051228 In: The journal of investigative dermatology. Symposium proceedings vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Endometrial cancer cells exhibit high expression of p110β and its selective inhibition induces variable responses on PI3K signaling, cell survival and proliferation. [electronic resource] by Karlsson, Thomas Krakstad, Camilla Tangen, Ingvild Løberg Hoivik, Erling A Pollock, Pamela M Salvesen, Helga B Lewis, Aurélia E Producer: 20180216 In: Oncotarget vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN status. [electronic resource] by Byron, Sara A Loch, David C Wellens, Candice L Wortmann, Andreas Wu, Jiayi Wang, John Nomoto, Kenichi Pollock, Pamela M Producer: 20130923 In: Molecular cancer vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Cellular settings mediating Src Substrate switching between focal adhesion kinase tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) tyrosine 734. [electronic resource] by Wortmann, Andreas He, Yaowu Christensen, Melinda E Linn, MayLa Lumley, John W Pollock, Pamela M Waterhouse, Nigel J Hooper, John D Producer: 20120221 In: The Journal of biological chemistry vol. 286 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	FGFR2 mutations are rare across histologic subtypes of ovarian cancer. [electronic resource] by Byron, Sara A Gartside, Michael G Wellens, Candice L Goodfellow, Paul J Birrer, Michael J Campbell, Ian G Pollock, Pamela M Producer: 20100330 In: Gynecologic oncology vol. 117 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	FGFR2-activating mutations disrupt cell polarity to potentiate migration and invasion in endometrial cancer cell models. [electronic resource] by Stehbens, Samantha J Ju, Robert J Adams, Mark N Perry, Samuel R Haass, Nikolas K Bryant, David M Pollock, Pamela M Producer: 20191018 In: Journal of cell science vol. 131 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features. [electronic resource] by Byron, Sara A Gartside, Michael Powell, Matthew A Wellens, Candice L Gao, Feng Mutch, David G Goodfellow, Paul J Pollock, Pamela M Producer: 20120827 In: PloS one vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Correction: Humanized bone facilitates prostate cancer metastasis and recapitulates therapeutic effects of Zoledronic acid in vivo. [electronic resource] by Landgraf, Marietta Lahr, Christoph A Sanchez-Herrero, Alvaro Meinert, Christoph Shokoohmand, Ali Pollock, Pamela M Hutmacher, Dietmar W Shafiee, Abbas McGovern, Jacqui A Publication details: Bone research In: Bone research vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2 [electronic resource] by Packer, Leisl M Geng, Xinyan Bonazzi, Vanessa F Ju, Robert J Mahon, Clare E Cummings, Margaret C Stephenson, Sally-Anne Pollock, Pamela M Producer: 20170801 In: Molecular cancer therapeutics vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	The "melanoma-enriched" microRNA miR-4731-5p acts as a tumour suppressor. [electronic resource] by Stark, Mitchell S Tom, Lisa N Boyle, Glen M Bonazzi, Vanessa F Soyer, H Peter Herington, Adrian C Pollock, Pamela M Hayward, Nicholas K Producer: 20180223 In: Oncotarget vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation. [electronic resource] by Byron, Sara A Gartside, Michael G Wellens, Candice L Mallon, Mary A Keenan, Jack B Powell, Matthew A Goodfellow, Paul J Pollock, Pamela M Producer: 20080918 In: Cancer research vol. 68 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

1
2
3
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 44 results.